Related Experiment Video
Updated: Aug 11, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
[Graves' disease in preschool children]
A Coca Pérez1, E Colino Alcol, M López Capapé
1Servicio de Pediatría, Hospital Ramón y Cajal, Madrid, Spain. pdacoca@hotmail.com
Insights
Graves
Area of Science:
- Pediatric Endocrinology
- Thyroidology
Background:
- Graves' disease is a leading cause of hyperthyroidism in children.
- It is exceptionally rare in preschool-aged children.
Observation:
- This study details four preschool girls diagnosed with Graves' disease.
- Presenting symptoms included tachycardia, diarrhea, developmental delay, and thyroid nodules.
- Ophthalmic manifestations were notably absent in all cases.
Findings:
- All patients exhibited elevated free T3 and T4 levels with suppressed TSH.
- Thyroid-stimulating immunoglobulins were detected in three patients.
- Two patients achieved complete remission with carbimazole treatment over five years.
Implications:
- Early diagnosis of Graves' disease in young children is crucial.
- The absence of ophthalmic signs does not rule out the condition.
- Carbimazole is an effective treatment option with a favorable safety profile in this age group.
Abstract:
Graves' disease, which is the main cause of hyperthyroidism in the pediatric age group, is very rare in pre-school children. We describe the cases of four girls, aged less than 6 years old, out of a total of 30 patients diagnosed with Graves' disease between 1985 and 2004. Investigations were motivated by tachycardia, chronic diarrhea, language development delay or thyroid nodules detected by cervical ultrasonography. In three of the four patients height and bone age were advanced. In all patients goiter was small or absent. None of the patients had ophthalmic disease. In all patients free T3 and T4 were elevated and thyroid-stimulating hormone was suppressed. Three patients were positive for thyroid-stimulating immunoglobulins (the method was not available for the oldest case). Two patients showed complete resolution after 5 years of treatment with carbimazole. The remaining two patients are still under treatment and no adverse effects have been documented.
Related Concept Videos
Drug Dosing: Infants and Children
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Hypothyroidism II: Pathophysiology
